Core Insights - Firefly Neuroscience, Inc. is participating in the Capital Event Management Conference from November 22-24, 2024, in Aventura, Florida [1] - The company specializes in developing AI solutions aimed at improving brain health outcomes for patients with neurological and mental disorders [4][5] Company Overview - Firefly is focused on innovative solutions that enhance diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD [4] - The company has developed the FDA-510(k) cleared Brain Network Analytics (BNA™) technology, which utilizes a proprietary database of brain wave tests and has secured patent protection [4][5] - BNA™ leverages artificial intelligence and machine learning on a database of standardized, high-definition longitudinal electroencephalograms (EEGs) from over 17,000 patients, providing comprehensive insights into brain function [5] Market Engagement - Firefly is launching BNA™ commercially, targeting pharmaceutical companies involved in drug research and clinical trials, as well as medical practitioners for clinical use [4] - The company aims to enhance clinicians' ability to accurately diagnose mental and cognitive disorders and evaluate optimal therapies for patients [5]
Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event